Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/09/2023 | 55.84% | Benchmark | $32 → $30 | Maintains | Buy |
08/24/2023 | 24.68% | Baird | $30 → $24 | Maintains | Neutral |
08/24/2023 | 29.87% | Credit Suisse | $33 → $25 | Maintains | Neutral |
08/23/2023 | 66.23% | Benchmark | $37 → $32 | Maintains | Buy |
08/23/2023 | 35.06% | UBS | $29 → $26 | Maintains | Neutral |
08/23/2023 | 35.06% | B of A Securities | $31 → $26 | Maintains | Underperform |
08/23/2023 | 55.84% | Canaccord Genuity | $38 → $30 | Maintains | Buy |
08/23/2023 | 29.87% | Piper Sandler | $44 → $25 | Downgrades | Overweight → Neutral |
06/15/2023 | 92.21% | Benchmark | → $37 | Reiterates | Buy → Buy |
05/08/2023 | 71.43% | Credit Suisse | $37 → $33 | Maintains | Neutral |
05/03/2023 | 55.84% | Baird | $43 → $30 | Downgrades | Outperform → Neutral |
05/03/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
04/18/2023 | 123.38% | Baird | $42 → $43 | Maintains | Outperform |
02/08/2023 | 118.18% | SVB Leerink | $46 → $42 | Maintains | Outperform |
01/27/2023 | 97.4% | Credit Suisse | → $38 | Upgrades | Underperform → Neutral |
11/18/2022 | 55.84% | JP Morgan | $41 → $30 | Maintains | Neutral |
11/03/2022 | 107.79% | Raymond James | $45 → $40 | Maintains | Outperform |
11/02/2022 | 112.99% | Baird | → $41 | Upgrades | Neutral → Outperform |
08/24/2022 | 138.96% | Benchmark | $44 → $46 | Maintains | Buy |
08/17/2022 | 138.96% | Canaccord Genuity | $44 → $46 | Maintains | Buy |
08/17/2022 | 97.4% | Credit Suisse | $35 → $38 | Maintains | Underperform |
05/04/2022 | 133.77% | Piper Sandler | $39 → $45 | Upgrades | Neutral → Overweight |
04/14/2022 | — | Guggenheim | Initiates Coverage On | → Neutral | |
08/19/2021 | 133.77% | Raymond James | $39 → $45 | Maintains | Outperform |
08/18/2021 | 138.96% | SVB Leerink | $44 → $46 | Maintains | Outperform |
05/28/2021 | 76.62% | Barclays | $42 → $34 | Downgrades | Overweight → Underweight |
05/05/2021 | 138.96% | Canaccord Genuity | $44 → $46 | Maintains | Buy |
02/04/2021 | 97.4% | Craig-Hallum | $33 → $38 | Maintains | Hold |
02/03/2021 | 102.6% | Raymond James | $37 → $39 | Maintains | Outperform |
02/03/2021 | 118.18% | Benchmark | → $42 | Upgrades | Hold → Buy |
02/03/2021 | 128.57% | SVB Leerink | $39 → $44 | Maintains | Outperform |
01/19/2021 | 87.01% | B of A Securities | → $36 | Downgrades | Buy → Underperform |
01/15/2021 | — | Credit Suisse | Downgrades | Neutral → Underperform | |
01/08/2021 | — | Jefferies | Downgrades | Buy → Hold | |
12/08/2020 | 118.18% | Berenberg | → $42 | Initiates Coverage On | → Buy |
08/31/2020 | 92.21% | Guggenheim | → $37 | Upgrades | Neutral → Buy |
08/27/2020 | 66.23% | UBS | $33 → $32 | Maintains | Neutral |
08/26/2020 | 92.21% | Raymond James | $40 → $37 | Maintains | Outperform |
08/26/2020 | 102.6% | SVB Leerink | $42 → $39 | Maintains | Outperform |
08/26/2020 | — | Benchmark | Downgrades | Buy → Hold | |
08/12/2020 | 81.82% | Credit Suisse | $37 → $35 | Maintains | Neutral |
05/12/2020 | 66.23% | SunTrust Robinson Humphrey | $30 → $32 | Maintains | Hold |
05/12/2020 | 118.18% | Cantor Fitzgerald | → $42 | Initiates Coverage On | → Overweight |
05/06/2020 | 87.01% | Baird | $34 → $36 | Maintains | Neutral |
05/06/2020 | 71.43% | UBS | $35 → $33 | Maintains | Neutral |
03/26/2020 | 55.84% | SunTrust Robinson Humphrey | $38 → $30 | Maintains | Hold |
02/11/2020 | 92.21% | Credit Suisse | $38 → $37 | Maintains | Neutral |
02/05/2020 | 87.01% | Baird | $41 → $36 | Maintains | Neutral |
02/05/2020 | 123.38% | Benchmark | $46 → $43 | Reiterates | → Buy |
11/11/2019 | — | Baird | Downgrades | Outperform → Neutral | |
10/31/2019 | 97.4% | UBS | $44 → $38 | Downgrades | Buy → Neutral |
10/15/2019 | 87.01% | Canaccord Genuity | → $36 | Upgrades | Hold → Buy |
08/13/2019 | 118.18% | Credit Suisse | $43 → $42 | Downgrades | Outperform → Neutral |
06/18/2019 | 112.99% | Guggenheim | → $41 | Initiates Coverage On | → Neutral |
05/02/2019 | 133.77% | Citigroup | → $45 | Upgrades | Neutral → Buy |
01/17/2019 | 133.77% | UBS | → $45 | Initiates Coverage On | → Buy |
What is the target price for Premier (PINC)?
The latest price target for Premier (NASDAQ: PINC) was reported by Benchmark on November 9, 2023. The analyst firm set a price target for $30.00 expecting PINC to rise to within 12 months (a possible 55.84% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Premier (PINC)?
The latest analyst rating for Premier (NASDAQ: PINC) was provided by Benchmark, and Premier maintained their buy rating.
When is the next analyst rating going to be posted or updated for Premier (PINC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Premier, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Premier was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Premier (PINC) correct?
While ratings are subjective and will change, the latest Premier (PINC) rating was a maintained with a price target of $32.00 to $30.00. The current price Premier (PINC) is trading at is $19.25, which is out of the analyst's predicted range.